Leap: molecular synthesisability scoring with intermediates

• URL: http://arxiv.org/abs/2403.13005v2
• Date: Fri, 12 Apr 2024 16:26:04 GMT
• Title: Leap: molecular synthesisability scoring with intermediates
• Authors: Antonia Calvi, Théophile Gaudin, Dominik Miketa, Dominique Sydow, Liam Wilbraham,
• Abstract summary: A common approach in drug discovery involves exploring the chemical space surrounding synthetically-accessible intermediates. Leap is a GPT-2 model trained on the depth, or longest linear path, of predicted synthesis routes. We show that Leap surpasses all other scoring methods by at least 5% on AUC score when identifying synthesisable molecules.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Assessing whether a molecule can be synthesised is a primary task in drug discovery. It enables computational chemists to filter for viable compounds or bias molecular generative models. The notion of synthesisability is dynamic as it evolves depending on the availability of key compounds. A common approach in drug discovery involves exploring the chemical space surrounding synthetically-accessible intermediates. This strategy improves the synthesisability of the derived molecules due to the availability of key intermediates. Existing synthesisability scoring methods such as SAScore, SCScore and RAScore, cannot condition on intermediates dynamically. Our approach, Leap, is a GPT-2 model trained on the depth, or longest linear path, of predicted synthesis routes that allows information on the availability of key intermediates to be included at inference time. We show that Leap surpasses all other scoring methods by at least 5% on AUC score when identifying synthesisable molecules, and can successfully adapt predicted scores when presented with a relevant intermediate compound.

Related papers

• SDDBench: A Benchmark for Synthesizable Drug Design [31.739548311094843]
  We propose a new, data-driven metric to evaluate molecule synthesizability. Our approach directly assesses the feasibility of synthetic routes for a given molecule through our proposed round-trip score. To demonstrate the efficacy of our method, we conduct a comprehensive evaluation of round-trip scores alongside search success rate across a range of representative molecule generative models.
  arXiv  Detail & Related papers  (2024-11-13T03:08:33Z)
• SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design [1.3927943269211591]
  This paper addresses the gap between in silico generative approaches and practical in vitro methodologies. We introduce SynthFormer, a novel ML model that utilizes a 3D equivariant encoder for pharmacophores to generate fully synthesizable molecules. Our contributions include a new methodology for efficient chemical space exploration using 3D information, a novel architecture called Synthformer for translating 3D pharmacophore representations into molecules, and a meaningful embedding space that organizes reagents for drug discovery optimization.
  arXiv  Detail & Related papers  (2024-10-03T17:38:46Z)
• BatGPT-Chem: A Foundation Large Model For Retrosynthesis Prediction [65.93303145891628]
  BatGPT-Chem is a large language model with 15 billion parameters, tailored for enhanced retrosynthesis prediction. Our model captures a broad spectrum of chemical knowledge, enabling precise prediction of reaction conditions. This development empowers chemists to adeptly address novel compounds, potentially expediting the innovation cycle in drug manufacturing and materials science.
  arXiv  Detail & Related papers  (2024-08-19T05:17:40Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design [62.68420322996345]
  Existing structured-based drug design methods treat all ligand atoms equally. We propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold. Our approach achieves state-of-the-art performance in generating high-affinity molecules.
  arXiv  Detail & Related papers  (2024-02-26T05:21:21Z)
• FSscore: A Machine Learning-based Synthetic Feasibility Score Leveraging Human Expertise [0.7045000393120925]
  This work introduces the Focused Synthesizability score(FSscore), which uses machine learning to rank structures based on their relative ease of synthesis. The FSscore showcases how a human-in-the-loop framework can be utilized to optimize the assessment of synthetic feasibility for various chemical applications.
  arXiv  Detail & Related papers  (2023-12-20T03:18:56Z)
• LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
  We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. Comprehensive experiments show that LIMO performs competitively on benchmark tasks. One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
  arXiv  Detail & Related papers  (2022-06-17T21:05:58Z)
• Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
  We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE) Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor. We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
  arXiv  Detail & Related papers  (2022-06-06T06:17:11Z)
• Neural networks for Anatomical Therapeutic Chemical (ATC) [83.73971067918333]
  We propose combining multiple multi-label classifiers trained on distinct sets of features, including sets extracted from a Bidirectional Long Short-Term Memory Network (BiLSTM) Experiments demonstrate the power of this approach, which is shown to outperform the best methods reported in the literature.
  arXiv  Detail & Related papers  (2021-01-22T19:49:47Z)
• Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning [75.95376096628135]
  We propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space. We describe how the end-to-end training in this study represents an important paradigm in radically expanding the synthesizable chemical space.
  arXiv  Detail & Related papers  (2020-04-26T21:40:03Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.